Back to results
US 8,946,184 B2Granted
Aptamer therapeutics useful in the treatment of complement-related disorders
AssigneeArchemix Corp.
InventorsClaude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
Life of this patent
Estimating the term…
Abstract
The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
Claims20
A compound comprising the nucleotide sequence of SEQ ID NO:
- 96, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.